J o u r n a l o f R h e u m a t i c D i s e a s e s V o l . Inflammatory myopathy is characterized by symmetrical proximal muscle weakness, elevated muscle enzyme levels and favorable response to glucocorticoids therapy. Although periorbital edema is a common manifestation of inflammatory myopathy, generalized subcutaneous edema is very rare. We report here a case of a 47-year-old female patient with acute polymyositis/systemic lupus erythematosus overlap syndrome with generalized subcutaneous edema and interstitial lung disease. We aggressively treated the disease with high-dose glucocorticoids, intravenous immunoglobulin, and immunosuppressive agents.
Introduction
Inflammatory myopathy is usually characterized by inflammation of proximal muscle, which results in muscle weakness and elevated muscle enzyme levels. As the disease progresses, esophageal and respiratory muscles may be affected. Other manifestations, such as skin lesions, arthritis, calcinosis, vasculitis and interstitial lung disease are relatively common (1,2).
Periorbital edema is not an uncommon manifestation of the disease, but generalized edema is rarely reported (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . There are no guidelines for the treatment of this condition and the clinical courses of reported cases have been variable.
We describe a case of polymyositis/systemic lupus erythematosus (SLE) overlap syndrome with severe generalized subcutaneous edema and interstitial lung disease. Magnetic resonance imaging (MRI) presented myositis and generalized edema, and chest computed tomography (CT) scan presented interstitial lung disease. The patient was treated successfully with corticosteroid, human intravenous immunoglobulin (IVIg), and immunosuppressive agents.
Case Report
A 47-year-old woman was admitted with progressive proximal muscle weakness, generalized swelling, fever, dysphagia, and dyspnea for 7 days. She had no history of diabetes mellitus, hypertension, or pulmonary tuberculosis, but had a 2-month history of rheumatoid arthritis. She was treated with hydroxychloroquine and nonsteroidal anti-inflammatory drug.
She had cancer screening including esophagogastroduodenoscopy and colonoscopy about 1 month ago, and no evidence was found of an underlying malignancy. Examination revealed a blood pressure of 130/64 mmHg, pulse rate of 105/min, respiratory rate of 20/min, and body temperature of 37. 
Discussion
This case had polymyositis/SLE overlap syndrome associated with generalized subcutaneous edema and interstitial lung disease. The clinical, laboratory, image, and biopsy findings in this case were all compatible with polymyositis associated with SLE. Non-pitting edema involved the face, trunk, and upper and lower extremities. Other conditions causing the edema were excluded (e.g., congestive heart failure, renal failure and liver cirrhosis). She had subclinical hypothyroidism and her TSH level was 12.34 uIU/mL, but it did not seem to be the cause of generalized edema because her T3 and free T4 levels were in reference range.
Some patients with inflammatory myositis also meet the cri- The association between inflammatory myopathy and generalized subcutaneous edema is extremely rare (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Affected patients usually had highly active diseases, with pronounced muscle weakness and sometimes with esophageal involvement. Of these cases, two cases were associated with malignancy: esophageal cancer and cervical cancer (10, 13) . The pathophysiology of generalized edema in inflammatory myopathy is unclear. The authors of previous reports had suggested that perivascular inflammation and endothelial damage through the autoimmune process may result in increased capillary permeability (3) (4) (5) 7) . Two cases were spontaneously recovered without any specific treatment (7, 10) . Six cases of active disease had esophageal involvement, and three of them died from respiratory failure despite of aggressive treatment (5, 12) . Initially, treatment with glucocorticoids can improve the degree of generalized edema and was used in most reported cases (3) (4) (5) (6) (7) (8) 11, 12) . Second-line treatments, including azathioprine, methotrexate and human IVIg were considered in purpose of steroid-sparing effect or in the severe cases (4, 5, 7, 8, 12) . Human IVIg is used as an alternative to azathioprine or methotrexate in inflammatory myopathy: some myositis experts suggested that when beginning therapy in severely affected patients or in rapidly progressive disease with high doses of prolonged corticosteroids, human IVIg was preferred (15) . In our case, the generalized edema was not well controlled by glucocorticoid therapy including high-dose oral prednisolone and intravenous pulse methylprednisolone, but responded to treatment with human IVIg. With decreased generalized edema, muscle weakness, dysphagia, and interstitial lung disease were improved. She had drug eruption of azathioprine, so we used oral prednisolone and tacrolimus for maintenance therapy.
Generalized subcutaneous edema could be an initial manifestation of inflammatory myopathies and is usually presenting in patients with very active disease course (5, 11) . In our case, a generalized subcutaneous edema is one of initial manifestations of inflammatory myopathy, and active and severe dis- 
Summary
We report a rare patient with polymyositis/SLE overlap syndrome associated with generalized subcutaneous edema. Her muscle power and edema were much improved after the third course of IVIg and maintenance therapy of tacrolimus. IVIg was an effective treatment in this case.
